Starling Oncology (STLN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.43, -6.95% vs the prior close of $6.91.
- Volume 1.77M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
STLN slides 6.9% to $6.43. Closed at $6.43, -6.95% vs the prior close of $6.91. Day range $6.34–$6.90, opened at $6.85.
STLN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — STLN slides 6.9% to $6.43
- Closed at $6.43, -6.95% vs the prior close of $6.91. Day range $6.34–$6.90, opened at $6.85.
- Volume was 1.77M shares, 1.3x its 50-day average of 1.40M.
- Price is +0.2% vs its 50-day average ($6.42) and +41.1% vs its 200-day average ($4.56).
- 52-week range $2.32–$7.13; today's close sits at 85% of that range, 9.8% below the 52-week high.
Oct 15, 2026 — STLN jumps 6.1% to $6.91
- Closed at $6.91, +6.14% vs the prior close of $6.51. Day range $6.36–$6.93, opened at $6.49.
- Volume was 1.19M shares, 0.8x its 50-day average of 1.40M.
- Price is +8.1% vs its 50-day average ($6.39) and +52.1% vs its 200-day average ($4.54).
- 52-week range $2.32–$7.13; today's close sits at 95% of that range, 3.1% below the 52-week high.
Oct 14, 2026 — STLN dips 2.8% to $6.51
- Closed at $6.51, -2.84% vs the prior close of $6.70. Day range $6.41–$6.75, opened at $6.68.
- Volume was 1.34M shares, 1.0x its 50-day average of 1.40M.
- Price is +2.5% vs its 50-day average ($6.35) and +43.8% vs its 200-day average ($4.53).
- 52-week range $2.32–$7.13; today's close sits at 87% of that range, 8.7% below the 52-week high.
Oct 13, 2026 — STLN slides 3.2% to $6.70
- Closed at $6.70, -3.18% vs the prior close of $6.92. Day range $6.68–$7.00, opened at $6.93.
- Volume was 1.28M shares, 0.9x its 50-day average of 1.40M.
- Price is +5.9% vs its 50-day average ($6.33) and +48.4% vs its 200-day average ($4.51).
- 52-week range $2.32–$7.13; today's close sits at 91% of that range, 6.0% below the 52-week high.
Oct 12, 2026 — STLN jumps 4.4% to $6.92
- Closed at $6.92, +4.37% vs the prior close of $6.63. Day range $6.60–$6.97, opened at $6.60.
- Volume was 965.00K shares, 0.7x its 50-day average of 1.40M.
- Price is +9.9% vs its 50-day average ($6.30) and +53.8% vs its 200-day average ($4.50).
- 52-week range $2.32–$7.13; today's close sits at 96% of that range, 2.9% below the 52-week high.
Oct 9, 2026 — STLN jumps 7.3% to $6.63
- Closed at $6.63, +7.28% vs the prior close of $6.18. Day range $6.18–$6.84, opened at $6.18.
- Volume was 1.85M shares, 1.3x its 50-day average of 1.38M.
- Price is +6.0% vs its 50-day average ($6.25) and +48.0% vs its 200-day average ($4.48).
- 52-week range $2.32–$7.13; today's close sits at 90% of that range, 7.0% below the 52-week high.
Oct 8, 2026 — STLN slides 3.9% to $6.18
- Closed at $6.18, -3.89% vs the prior close of $6.43. Day range $6.12–$6.41, opened at $6.39.
- Volume was 1.25M shares, 0.9x its 50-day average of 1.38M.
- Price is -0.7% vs its 50-day average ($6.22) and +38.4% vs its 200-day average ($4.46).
- 52-week range $2.32–$7.13; today's close sits at 80% of that range, 13.3% below the 52-week high.
Oct 7, 2026 — STLN dips 2.3% to $6.43
- Closed at $6.43, -2.28% vs the prior close of $6.58. Day range $6.38–$6.79, opened at $6.50.
- Volume was 949.10K shares, 0.7x its 50-day average of 1.41M.
- Price is +3.8% vs its 50-day average ($6.19) and +44.5% vs its 200-day average ($4.45).
- 52-week range $2.32–$7.13; today's close sits at 85% of that range, 9.8% below the 52-week high.
Oct 6, 2026 — STLN jumps 4.4% to $6.58
- Closed at $6.58, +4.44% vs the prior close of $6.30. Day range $6.36–$6.64, opened at $6.38.
- Volume was 985.80K shares, 0.7x its 50-day average of 1.42M.
- Price is +6.7% vs its 50-day average ($6.17) and +48.3% vs its 200-day average ($4.44).
- 52-week range $2.32–$7.13; today's close sits at 89% of that range, 7.7% below the 52-week high.
Oct 5, 2026 — STLN dips 0.8% to $6.30
- Closed at $6.30, -0.79% vs the prior close of $6.35. Day range $6.20–$6.36, opened at $6.33.
- Volume was 1.34M shares, 0.9x its 50-day average of 1.41M.
- Price is +2.7% vs its 50-day average ($6.14) and +42.5% vs its 200-day average ($4.42).
- 52-week range $2.32–$7.13; today's close sits at 83% of that range, 11.6% below the 52-week high.
Oct 2, 2026 — STLN rises 2.2% to $6.35
- Closed at $6.35, +2.17% vs the prior close of $6.22. Day range $6.22–$6.38, opened at $6.36.
- Volume was 793.90K shares, 0.6x its 50-day average of 1.42M — lighter than usual.
- Price is +3.9% vs its 50-day average ($6.11) and +44.1% vs its 200-day average ($4.41).
- 52-week range $2.32–$7.13; today's close sits at 84% of that range, 10.9% below the 52-week high.
STLN latest news & SEC filings
Every SEC filing by or about STLN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hively Brad sold 298,853 shares at $6.51 (≈$1.95M) on Aug 21, 2026
- Hively Brad sold 298,853 shares at $6.51 (≈$1.95M) on Aug 21, 2026
- Hively Brad sold 298,853 shares at $6.51 (≈$1.95M) on Aug 21, 2026
- Hively Brad sold 298,853 shares at $6.51 (≈$1.95M) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chernett Jorey bought 12,000 shares at $6.54 (≈$78.48K) on Aug 14, 2026
- Chernett Jorey bought 12,000 shares at $6.54 (≈$78.48K) on Aug 14, 2026
- Chernett Jorey bought 12,000 shares at $6.54 (≈$78.48K) on Aug 14, 2026
- Chernett Jorey bought 12,000 shares at $6.54 (≈$78.48K) on Aug 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $161.28M (prior year $119.80M) (+34.6% vs Jun 30, 2025)
- Net income: -$9.79M (prior year -$17.01M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade STLN
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.32% (largest 7.3%). That is a volatile stock.
- Liquidity: about 1.19M shares (≈$7.67M) trade per day on average.
- 52-week position: $6.43 vs a range of $2.32–$7.13 (85% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 13 open-market buys, 12 sales; latest: Brad Hively sold 298,853 shares on Aug 21, 2026.
- Latest filings: 8-K Sep 2, 2026; 8-K Aug 21, 2026; 10-Q Aug 6, 2026.
- Share count: 101.92M shares outstanding (Jul 30, 2026), +9.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Offices & Clinics of Doctors of Medicine.
STLN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.85 | 6.90 | 6.34 | 6.43 | 1.77M |
| Oct 15, 2026 | 6.49 | 6.93 | 6.36 | 6.91 | 1.19M |
| Oct 14, 2026 | 6.68 | 6.75 | 6.41 | 6.51 | 1.34M |
| Oct 13, 2026 | 6.93 | 7.00 | 6.68 | 6.70 | 1.28M |
| Oct 12, 2026 | 6.60 | 6.97 | 6.60 | 6.92 | 965.00K |
| Oct 9, 2026 | 6.18 | 6.84 | 6.18 | 6.63 | 1.85M |
| Oct 8, 2026 | 6.39 | 6.41 | 6.12 | 6.18 | 1.25M |
| Oct 7, 2026 | 6.50 | 6.79 | 6.38 | 6.43 | 949.10K |
| Oct 6, 2026 | 6.38 | 6.64 | 6.36 | 6.58 | 985.80K |
| Oct 5, 2026 | 6.33 | 6.36 | 6.20 | 6.30 | 1.34M |
| Oct 2, 2026 | 6.36 | 6.38 | 6.22 | 6.35 | 793.90K |
| Oct 1, 2026 | 6.30 | 6.43 | 6.18 | 6.22 | 994.20K |
| Sep 30, 2026 | 6.51 | 6.59 | 6.32 | 6.32 | 946.90K |
| Sep 29, 2026 | 6.73 | 6.73 | 6.34 | 6.51 | 972.90K |
| Sep 28, 2026 | 6.59 | 6.79 | 6.48 | 6.64 | 919.20K |
| Sep 25, 2026 | 6.50 | 6.86 | 6.41 | 6.66 | 1.13M |
| Sep 24, 2026 | 6.72 | 6.95 | 6.38 | 6.51 | 1.76M |
| Sep 23, 2026 | 7.00 | 7.00 | 6.61 | 6.82 | 1.12M |
| Sep 22, 2026 | 6.92 | 7.07 | 6.76 | 7.05 | 1.05M |
| Sep 21, 2026 | 6.98 | 7.05 | 6.73 | 6.83 | 1.25M |
About Starling Oncology
Starling Oncology (STLN) is listed on the Nasdaq and classified by the SEC under “Services-Offices & Clinics of Doctors of Medicine”. Its business address is in CERRITOS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1799191.
STLN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brad Hively | Director | Aug 24, 2026 |
| Karen Marie Johnson | Director | Jul 29, 2026 |
| Mohit Kaushal | Director | Jul 29, 2026 |
| Gabriel Ling | Director | Dec 1, 2025 |
| Growth I Gp Llc M33 | Director | Nov 20, 2025 |
| Growth I L.P. M33 | Director | Nov 20, 2025 |
| Anne Mcgeorge | Director | Jul 29, 2026 |
| Mark L Pacala | Director | Jul 29, 2026 |
| Mark Stolper | Director | Jul 29, 2026 |
| M, Llc Toi | Director | Nov 20, 2025 |
| Kimberly Jo Tzoumakas | Director | Jul 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert Ross Carter | Chief Financial Officer | May 22, 2026 |
| Kristin England | Chief Administrative Officer | Apr 23, 2026 |
| Jeffrey Langsam | Chief Clinical Officer | Apr 23, 2026 |
| Yale Podnos | Chief Medical Officer | Jul 16, 2026 |
| Daniel Virnich | Chief Executive Officer | May 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Brad Hively | Sale | 298,853 | $6.51 |
| Aug 21, 2026 | Brad Hively | Sale | 298,853 | $6.51 |
| Aug 21, 2026 | Brad Hively | Sale | 298,853 | $6.51 |
| Aug 21, 2026 | Brad Hively | Sale | 298,853 | $6.51 |
| Aug 14, 2026 | Jorey Chernett | Buy | 12,000 | $6.54 |
| Aug 14, 2026 | Jorey Chernett | Buy | 12,000 | $6.54 |
| Aug 14, 2026 | Jorey Chernett | Buy | 12,000 | $6.54 |
| Aug 14, 2026 | Jorey Chernett | Buy | 12,000 | $6.54 |
| Jul 21, 2026 | Jorey Chernett | Buy | 18,000 | $5.27 |
| Jul 21, 2026 | Jorey Chernett | Buy | 18,000 | $5.27 |
| Jul 21, 2026 | Jorey Chernett | Buy | 18,000 | $5.27 |
| Jul 21, 2026 | Jorey Chernett | Buy | 18,000 | $5.27 |
| Jul 14, 2026 | Yale Podnos | Sale | 5,478 | $6.35 |
| Jul 14, 2026 | Yale Podnos | Sale | 17,974 | $6.43 |
| Jul 14, 2026 | Yale Podnos | Sale | 5,478 | $6.35 |
STLN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $502.73M | $-60.61M | -0.54 | $-24.59M |
| Dec 31, 2024 | $393.41M | $-64.66M | -0.71 | $-26.54M |
| Dec 31, 2023 | $324.24M | $-83.07M | -0.92 | $-36.31M |
| Dec 31, 2022 | $252.48M | $152.00K | -0.21 | $-61.76M |
| Dec 31, 2021 | $203.00M | $-10.93M | -0.16 | $-32.68M |
Latest balance sheet: total assets $178.23M, total liabilities $203.15M, cash $200.00K (as of Jun 30, 2026).
STLN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.99 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.07 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $2.62 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $3.85 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $3.08 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $4.10 |
| May 14, 2025 | 8-K Item 2.02 (results) | $2.37 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $1.24 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $0.26 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Apr 3, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Offices & Clinics of Doctors of Medicine
Hims & Hers Health (HIMS)Teladoc Health (TDOC)LifeMD (LFMD)Airsculpt Technologies (AIRS)Basel Medical (BMGL)SBC Medical (SBC)Auna (AUNA)Westin Acquisition (WSTN)Concord Medical Services (CCM)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on STLN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.